Simvastatin inhibits calcific nodule formation in valvular interstitial cells via a ROCK-dependent pathway, with efficacy varying by extracellular environment.
No takes yet. Share an insight, caveat, or question.
No immediate clinical role for simvastatin in calcific valve disease; leaves open ROCK pathway targeting in valvular interstitial cells.
Monzack et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: